Inmar Insights: Healthcare

The Pharmacy Supply Chain Is Ready for Its Digital Reckoning

Pharmacy supply chains rely on outdated, fragmented systems that create medication errors, waste, and stockouts. AI and predictive analytics offer a solution by improving visibility, forecasting demand, and enabling more responsive, data-driven operations.

• Read more about The Pharmacy Supply Chain Is Ready for Its Digital Reckoning

The Case for Intelligent Solutions in a Rapidly Evolving Recall Landscape

By: Paige Ivey, Sr. Director, Healthcare The U.S. healthcare system is grappling with a growing and underappreciated threat: the sharp rise in medical device recalls. In the first half of 2024, over 570 medical device recalls were reported, an alarming 30% year-over-year increase, impacting more than 670 million units.

• Read more about The Case for Intelligent Solutions in a Rapidly Evolving Recall Landscape

Why Recall Preparedness Is a Business Imperative in Pharma

Product recalls are one of the most serious challenges a pharmaceutical company can face. The consequences of mishandling a recall reach far beyond lost product—they can endanger patient safety, trigger regulatory action, and cause lasting damage to a company’s credibility. Despite this, many organizations continue to treat recall planning as an afterthought rather than an operational priority.

• Read more about Why Recall Preparedness Is a Business Imperative in Pharma

Beyond Compliance: How Decommissioning Serial Numbers Strengthens the Pharma Supply Chain

Decommissioning serial numbers is emerging as a critical best practice in the pharmaceutical industry, enhancing DSCSA compliance and supply chain integrity. By formally retiring products from the supply chain using standardized EPCIS data, manufacturers can prevent fraud, support audits, and improve traceability. This proactive step strengthens patient safety and protects against the re-entry of counterfeit or expired drugs.

• Read more about Beyond Compliance: How Decommissioning Serial Numbers Strengthens the Pharma Supply Chain

The Specialty Pharmacy Squeeze

Specialty pharmacies are under growing financial pressure due to high drug costs, delayed reimbursements, and limited access to support programs like 340B. This cash-flow strain threatens patient access—especially in underserved areas—as some pharmacies are forced to close or exit the market. Addressing the crisis requires faster payments, expanded program access, and reform of pharmacy benefit manager practices to ensure the sustainability of specialty care.

• Read more about The Specialty Pharmacy Squeeze

Reckoning with Waste: Rethinking Medication Management in U.S. Hospitals

Medication waste in hospitals stems from outdated inventory practices and poor visibility. By adopting real-time data and automation, health systems can reduce waste, improve care readiness, and enhance operational efficiency.

• Read more about Reckoning with Waste: Rethinking Medication Management in U.S. Hospitals

Pharmacies, Meet Your Most Underrated Asset

Reverse distribution is pharmacy’s secret weapon—cutting costs, easing compliance burdens, and fueling smarter planning. In this VerifiedRx episode, Inmar and Vizient experts unpack how this often-overlooked process boosts efficiency, supports sustainability, and keeps supply chains strong. A vital listen for health system leaders and pharmacy pros ready to level up logistics strategy.

• Read more about Pharmacies, Meet Your Most Underrated Asset

Why Hospitals are Racing to Secure Essential Medications

Persistent drug shortages are pushing hospitals to rethink supply chains, adopt new technologies, and advocate for policies that ensure critical medication access.

• Read more about Why Hospitals are Racing to Secure Essential Medications

How Life Science Manufacturers Can Tackle the Industry’s Toughest Recall Challenges

Pharmaceutical recalls are complex and high-risk. This article breaks down the top challenges manufacturers face and offers proactive strategies to manage recalls efficiently and protect patient safety.

• Read more about How Life Science Manufacturers Can Tackle the Industry’s Toughest Recall Challenges